DNA tetrahedral biosensor and construction method and application thereof

By designing a DNA tetrahedral biosensor and utilizing the enzymatic digestion of APE1 and the hybridization reaction of miRNA-221, a highly sensitive detection of APE1 and miRNA-221 was achieved, solving the problems of high cost and low sensitivity of existing detection methods. This has important significance for cancer diagnosis and drug screening.

CN118910040APending Publication Date: 2024-11-08HUNAN UNIV OF CHINESE MEDICINE
View PDF 0 Cites 1 Cited by

Patent Information

Application Number
CN202410958987.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-17
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Existing detection methods are limited by expensive instruments, low sensitivity, false positives, and extracellular detection, making it impossible to effectively detect APE1 and miRNA-221 simultaneously.

Method used

A DNA tetrahedral biosensor was designed to achieve high-sensitivity target detection and signal amplification through the assembly reaction of FTDN-1 and FTDN-2, the enzymatic cleavage of APE1, and the hybridization reaction of miRNA-221.

Benefits of technology

High-sensitivity detection of APE1 and miRNA-221 was achieved, with detection limits of 0.28 U/mL and 0.26 nM, respectively, enabling accurate identification of cancer cells and their use in drug screening and cancer diagnosis.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118910040A_ABST
    Figure CN118910040A_ABST
Patent Text Reader

Abstract

The invention is suitable for the technical field of biochemical analysis, and provides a DNA tetrahedral biosensor and a construction method and application thereof. The DNA tetrahedral biosensor comprises an FTDN-1 and an FTDN-2; the FTDN-1 is formed by hybridizing and assembling an extension sequence of a TDN-1 vertex with Cy5 and BHQ2 modified H1 and H2 hairpin structures and a BHQ2 modified S5 single chain respectively; the TDN-1 is obtained by mixed reaction of an S1 single chain, an S2 single chain, an S3 single chain and an S4 single chain; the FTDN-2 is formed by hybridizing and assembling an extension sequence of a top point of the TDN-2 with Cy5 and BHQ2 modified H1 and H2 hairpin structures and a BHQ2 modified S6 single chain respectively; the TDN-2 is obtained by carrying out mixed reaction on an S1 single chain, an S2-2 single chain, an S3 single chain and an S4-2 single chain; the application disclosed by the invention can be used for performing high-selectivity simultaneous detection and intracellular imaging on APE1 and miRNA-221.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application belongs to the field of biochemical analysis technology, and in particular relates to a DNA tetrahedron biosensor and a construction method and application thereof. Background Art

[0002] Abnormal expression of key biological molecules in cells is closely related to the occurrence and development of cancer and can be used as a biomarker for early cancer diagnosis. APE1, as a key enzyme involved in the DNA base excision repair pathway, can specifically recognize AP sites in DNA. APE1 is overexpressed in many cancers such as lung cancer, breast cancer, and gastroesophageal cancer and maintains a low level in normal cells. In addition, overexpression of APE1 may increase chemotherapy resistance. Based on this, APE1 has important research value as a potential cancer diagnostic biomarker and therapeutic target. microRNA-221 (miRNA-221) is a class of non-coding RNA molecules that plays an indispensable role in gene regulation. A large number of studies have shown that miRNA-221 is highly expressed in a variety of cancer cells including breast cancer and lung cancer. Based on this, miRNA-221 is considered to be an effective biomarker for diagnosing early cancer. Unlike single-target detection, simultaneous detection of intracellular APE1 and miRNA can accurately distinguish cancer cells from normal cells, which can effectively avoid false positive results. Therefore, simultaneous imaging of intracellular APE1 and miRNA-221 is of great significance for accurate identification of cancer cells, drug screening, and even cancer diagnosis.

[0003] Existing detection methods are limited by expensive instruments, low sensitivity, false positives, and extracellular detection. With the development of DNA nanotechnology, DNA tetrahedron nanostructures are widely used in biosensing, bioimaging, and drug delivery due to their significant advantages, such as specific self-assembly ability through base pairing, precise control of size and shape, and good biocompatibility. Combining multiple signal amplification strategies to construct functionalized DNA tetrahedrons, high-sensitivity and high-specificity activity detection of DNA repair enzymes is achieved, which is of great significance for drug screening and cancer diagnosis. So far, there has been no report on the simultaneous detection of APE1 and miRNA-221 dual targets by biosensors based on DNA tetrahedron nanostructures. Summary of the invention

[0004] The purpose of the embodiments of the present application is to provide a DNA tetrahedron biosensor, which aims to solve the problems of existing detection methods being limited by expensive instruments, low sensitivity, false positives and extracellular detection.

[0005] The embodiment of the present application is implemented as follows: a DNA tetrahedron biosensor, wherein the DNA tetrahedron biosensor includes FTDN-1 and FTDN-2;

[0006] The FTDN-1 is formed by hybridization and assembly of the extended sequences of the four vertices of TDN-1 with the H1 and H2 hairpin structures modified by Cy5 and BHQ2 and the S5 single strand modified by BHQ2; the TDN-1 is obtained by the mixed reaction of the S1 single strand, the S2 single strand, the S3 single strand and the S4 single strand;

[0007] The FTDN-2 is formed by hybridization and assembly of the extended sequences of the four vertices of TDN-2 with the H1 and H2 hairpin structures modified by Cy5 and BHQ2 and the S6 single strand modified by BHQ2; the TDN-2 is obtained by the mixed reaction of the S1 single strand, the S2-2 single strand, the S3 single strand and the S4-2 single strand;

[0008] The sequences from 5' to 3' of S1, S2, S3, S4, S2-2, S4-2, S5, S6, H1, and H2 are shown as SEQ ID NO. 1 to SEQ ID NO. 10, respectively.

[0009] Another object of the present application is to provide a method for constructing the above-mentioned DNA tetrahedron biosensor, comprising:

[0010] The S1 single chain, the S2 single chain, the S3 single chain and the S4 single chain were mixed in an equal molar ratio to obtain TDN-1;

[0011] The S1 single chain, the S2-2 single chain, the S3 single chain and the S4-2 single chain were mixed in an equal molar ratio to obtain TDN-2;

[0012] After the H1 single strand and the H2 single strand are reacted, they are annealed to form the H1 and H2 hairpin structures;

[0013] The TDN-1 is mixed with the H1, H2 hairpin structures and S5 single chain, and incubated to obtain FTDN-1;

[0014] The TDN-2 is mixed with the H1, H2 hairpin structures and S6 single chain, and incubated to obtain FTDN-2.

[0015] Another object of the embodiments of the present application is to provide an application of the above-mentioned DNA tetrahedron biosensor in the simultaneous detection of APE1 enzyme and miRNA-221.

[0016] Another object of the embodiments of the present application is to provide an application of the above-mentioned DNA tetrahedron biosensor in drug screening.

[0017] The DNA tetrahedron biosensor provided in the embodiment of the present application is assembled into FTDN-1 and FTDN-2 by extending a sequence at the 3' end of the four single-stranded DNAs (SSDNA) of two DNA tetrahedrons (TDN) as a binding site, and respectively with H1 (modified with Cy5 and BHQ2), H2 and single-stranded S5 (modified with BHQ2 and AP), S6 (modified with BHQ2). When tumor cells overexpress APE1 and miRNA-221, APE1 specifically recognizes the AP site on the S5 chain, thereby enzymatically cleaving the S5 chain into two parts, thereby releasing the Cy3-modified extended chain in FTDN-1 to combine with the Cy3-modified complementary chain in FTDN-2, triggering an entropy-driven tetrahedron assembly reaction. Through this reaction, FTDN-1 and FTDN-2 are continuously and dynamically hybridized and connected to form a polymerized DNA tetrahedron assembly FTDN-1 / FTDN-2. At the same time, miRNA-221 opens H2 in FTDN-1 and FTDN-2, exposing the H2 binding site and hybridizing and complementing with H1 of FTDN-1 and FTDN-2. MiRNA-221 is released to continue hybridizing with H2, realizing the double CHA cycle reaction in the tetrahedron of FTDN-1 and FTDN-2. In addition, the FRET signal between Cy5 and BHQ2 in H1 changes from "on" to "off", generating a Cy5 fluorescence signal, thereby realizing the signal amplification detection of miRNA-221. When the two targets exist at the same time, the fluorescence signals of Cy3 and Cy5 rise at the same time. The change in the fluorescence signal can realize the quantitative detection of the two targets, and the detection of the two targets is linear in 0-10nM. The present application has high sensitivity for the detection of APE1 and miRNA-221, and its detection limits are 0.28U / mL and 0.26nM, respectively. DNA tetrahedron can be internalized by cells through the caveolin-dependent pathway. The good biological stability and cellular internalization ability of this biosensor are beneficial for imaging and analyzing APE1 and miRNA-221 in cells, which is of great significance for accurate identification of cancer cells, drug screening and even cancer diagnosis. BRIEF DESCRIPTION OF THE DRAWINGS

[0018] The drawings in the specification, which constitute a part of this application, are used to provide a further understanding of the present disclosure. The illustrative embodiments of the present disclosure and their descriptions are used to explain the present disclosure and do not constitute an improper limitation on the present disclosure.

[0019] Figure 1 A schematic diagram of an embodiment of the present application.

[0020] Figure 2 The gel electrophoresis provided in the examples of the present application verifies the construction of TDN (A) and FTDN (C) in the DNA tetrahedron biosensor and the feasibility of fluorescence detection of APE1 (B) and miRNA-221 (D).

[0021] Figure 3 This is a diagram of the optimization of experimental parameters for measuring APE1 and miRNA-221 using the DNA tetrahedron biosensor provided in the examples of the present application.

[0022] Figure 4 This is a diagram showing the sensitivity and specificity of the DNA tetrahedron biosensor provided in the examples of the present application for measuring APE1 and miRNA-221.

[0023] Figure 5 This is a diagram showing the detection specificity of APE1 and miRNA-221 using the DNA tetrahedron biosensor provided in the examples of the present application.

[0024] Figure 6 This is a graph showing the results of using the DNA tetrahedron biosensor provided in an embodiment of the present application to screen the effects of 12 anti-tumor compounds derived from traditional Chinese medicine on the activity of APE1.

[0025] Figure 7 The feasibility of the DNA tetrahedron biosensor provided in the embodiments of the present application for intracellular imaging of APE1 and miRNA-221.

[0026] Figure 8 The DNA tetrahedron biosensor provided in the embodiments of the present application images APE1 and miRNA-221 in different cells. DETAILED DESCRIPTION

[0027] In order to make the purpose, technical solution and advantages of the present application more clearly understood, the present application is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present application and are not used to limit the present application.

[0028] The embodiment of the present application provides a DNA tetrahedron biosensor, wherein the DNA tetrahedron biosensor includes FTDN-1 and FTDN-2;

[0029] The FTDN-1 is formed by hybridization and assembly of the extended sequences of the four vertices of TDN-1 with the H1 and H2 hairpin structures modified by Cy5 and BHQ2 and the S5 single strand modified by BHQ2; the TDN-1 is obtained by the mixed reaction of the S1 single strand, the S2 single strand, the S3 single strand and the S4 single strand;

[0030] The FTDN-2 is formed by hybridization and assembly of the extended sequences of the four vertices of TDN-2 with the H1 and H2 hairpin structures modified by Cy5 and BHQ2 and the S6 single strand modified by BHQ2; the TDN-2 is obtained by the mixed reaction of the S1 single strand, the S2-2 single strand, the S3 single strand and the S4-2 single strand;

[0031] The 5' to 3' sequences of S1, S2, S3, S4, S2-2, S4-2, S5, S6, H1, and H2 are shown in SEQ ID NO.1 to SEQ ID NO.10, respectively.

[0032] S1 (SEQ ID NO.1):

[0033] 5'-TATCACCAGGCAGTTGACAGTGTAGCAAGCTGTAATAGATGCGAGGGTCCAATACtttGGAGAGGACGATGTGT-3';

[0034] S2 (SEQ ID NO.2):

[0035] 5'-TTCGGACAAAATG / iCy3 / CAGCGTCATATCAGGGAGGGGGTACCtttT CAACTGCCTGGTGATAAAACGACACTACGTGGGAATCTACTATGGCGGCT CTTC-3';

[0036] S3 (SEQ ID NO.3):

[0037] 5'-TTCAGACTTAGGAATGTGCTTCCCACGTAGTGTCGTTTGTATTGGACCCTCGCATtttGGTGTGCAGTTTGGAA-3';

[0038] S4 (SEQ ID NO.4):

[0039] 5'-TTCGGACAAAATG / iCy3 / CAGCGTCATATCAGGGAGGGGGTACCtttA CATTCCTAAGTCTGAAACATTACAGCTTGCTACACGAGAAGAGCCGCCAT AGTA-3';

[0040] S5 (SEQ ID NO.5): 5'-CCCCTC / idSp / CTGATA / idSp / GACGCT(BHQ2)-3'; S6 (SEQ ID NO.6): 5'-(BHQ2)-GACAAAATGGCAGCG-3';

[0041] S2-2 (SEQ ID NO.7):

[0042] 5'-CCCTCCCTGATATGACGCTGCCATTTTG / iCy3 / CCGAAtttTCAACTGC CTGGTGATAAAACGACACTACGTGGGAATCTACTATGGCGGCTCTTC-3';

[0043] S4-2 (SEQ ID NO.8):

[0044] 5'-CCCTCCCTGATATGACGCTGCCATTTTG / iCy3 / CCGAAtttACATTCCT AAGTCTGAAACATTACAGCTTGCTACACGAGAAGAGCCGCCATAGTA-3';

[0045] H1 (SEQ ID NO.9):

[0046] 5'-ACACATCGTCCTCTCCtt / iBHQ2dT / AAAGTCCTATGAATTGTCTGCTGGGTTTCATAGAGCTTT / iCy5 / GCTCAACATC-3';

[0047] H2 (SEQ ID NO.10):

[0048] 5'-TTCCAAACTGCACACCtttCGCGTTGTCTGCTGGGTTTCGCAAAGCTCTATGAAACCCAGCAGACAATGTAGCT-3'.

[0049] The present application also provides a method for constructing the above-mentioned DNA tetrahedron biosensor, comprising:

[0050] The S1 single chain, the S2 single chain, the S3 single chain and the S4 single chain were mixed in an equal molar ratio to obtain TDN-1;

[0051] The S1 single chain, the S2-2 single chain, the S3 single chain and the S4-2 single chain were mixed in an equal molar ratio to obtain TDN-2;

[0052] After the H1 single strand and the H2 single strand are reacted, they are annealed to form the H1 and H2 hairpin structures;

[0053] The TDN-1 is mixed with the H1, H2 hairpin structures and S5 single chain, and incubated to obtain FTDN-1;

[0054] The TDN-2 is mixed with the H1, H2 hairpin structures and S6 single chain, and incubated to obtain FTDN-2.

[0055] The step of mixing the S1 single strand, the S2 single strand, the S3 single strand and the S4 single strand in an equal molar ratio to obtain TDN-1 comprises:

[0056] S1 single chain, S2 single chain, S3 single chain and S4 single chain were mixed in TE buffer at an equal molar ratio, reacted at 95°C for 10 minutes, placed on ice for 5 minutes to quickly cool the solution, and kept at 4°C for at least 35 minutes to obtain TDN-1.

[0057] The step of mixing the S1 single strand, the S2-2 single strand, the S3 single strand and the S4-2 single strand in an equal molar ratio to obtain TDN-2 comprises:

[0058] S1 single chain, S2-2 single chain, S3 single chain and S4-2 single chain were mixed in TE buffer at an equal molar ratio, reacted at 95°C for 10 minutes, placed on ice for 5 minutes to quickly cool the solution, and kept at 4°C for at least 35 minutes to obtain TDN-2.

[0059] The step of reacting the H1 single strand and the H2 single strand and then annealing them to form the H1 and H2 hairpin structures comprises:

[0060] The H1 single strand and the H2 single strand were placed at 95°C for 5 minutes and gradually annealed to 25°C to form H1 and H2 hairpin structures.

[0061] The step of mixing the TDN-1 with the H1, H2 hairpin structures and S5 single strand and incubating to obtain FTDN-1 comprises:

[0062] The TDN-1 was mixed evenly with the H1 and H2 hairpin structures and the S5 single chain, and incubated at 37° C. for 1 hour to obtain FTDN-1.

[0063] The step of mixing the TDN-2 with the H1, H2 hairpin structures and S6 single strand and incubating to obtain FTDN-2 comprises:

[0064] The TDN-2 was mixed evenly with the H1 and H2 hairpin structures and the S6 single strand, and incubated at 37° C. for 1 hour to obtain FTDN-2.

[0065] The working principle of this application is:

[0066] (1) FTDN-1 is composed of seven DNA strands, namely S1, S2, S3, S4, S5, H1, and H2; FTDN-2 is composed of seven DNA strands, namely S1, S2-2, S3, S4-2, S6, H1, and H2.

[0067] (2) In the absence of a target, Cy5 at the 3' end of H1 and BHQ2 at the 5' end are close to each other, and Cy3 at the 5' end of S2 and S4 (S2-2 and S4-2) and BHQ2 at the 3' end of S5 (5' end of S6) are close to each other. The fluorescence of Cy3 and Cy5 is quenched, resulting in a lower background signal.

[0068] (3) In the presence of the target APE1, APE1 specifically recognizes the AP site on the S5 chain and cleaves the S5 chain, thereby releasing the extended chain modified by Cy3 in FTDN-1 and combining with the complementary chain modified by Cy3 in FTDN-2, triggering an entropy-driven tetrahedral assembly reaction. Cy3 moves away from BHQ2, and the fluorescence signal of Cy3 rebounds. In the presence of the target miRNA-221, H2 binds to miRNA-221, exposing the H2 binding site and hybridizing with H1. Cy5 in H1 moves away from BHQ2, and the fluorescence signal of Cy5 rebounds. miRNA-221 is released and continues to hybridize with H2, realizing a double CHA cycle reaction within the tetrahedron of FTDN-1 and FTDN-2.

[0069] The DNA tetrahedron biosensor designed in this application can be used for highly selective simultaneous detection and intracellular imaging of APE1 and miRNA-221.

[0070] The fluorescence detection conditions were set as follows: excitation wavelength: 530 nm and 635 nm, excitation slit: 10 nm, emission slit: 10 nm, voltage: 700 V.

[0071] The specific implementation scheme of the present application is further described in detail below in conjunction with the accompanying drawings and examples. The following examples are used to illustrate the present application, but do not limit the scope of application and expansion of the present application.

[0072] Example 1: Construction of a rigid quadrilateral DNA biosensor for simultaneous detection of APE1 and miRNA-221.

[0073] The preparation process of TDN-1 is as follows: 4 single-stranded DNAs (S1, S2, S3, S4) are mixed in TE buffer at an equal molar ratio, reacted at 95°C for 10 minutes, and then placed on ice for 5 minutes to rapidly cool the solution, and kept at 4°C for at least 35 minutes. The synthesis of TDN-2 uses 4 single-stranded DNAs (S1, S2-2, S3, S4-2), and the reaction procedure is the same as the preparation process of TDN-1.

[0074] FTDN-1 is formed by the hybridization assembly of the extended sequences of the four vertices of TDN-1 with the hairpin structures of H1 and H2 modified by Cy5 and BHQ2 and the single-stranded S5 modified by BHQ2. First, the H1 and H2 solutions were reacted at 95°C for 5 minutes and gradually annealed to 25°C to form the hairpin structure. Next, the prepared TDN-1 was mixed with the corresponding concentrations of H1 and H2 at a molar ratio of 1:1, and mixed with the corresponding concentration of S5 (TDN-1:S5=1:2), and incubated at 37°C for 1 hour to prepare FTDN-1, which was stored in a 4°C refrigerator for subsequent use. FTDN-2 is formed by the hybridization assembly of the extended sequences of the four vertices of TDN-2 with the hairpin structures of H1 and H2 modified by Cy5 and BHQ2 and the single-stranded S6 modified by BHQ2. The subsequent reaction procedure is the same as the preparation process of FTDN-1.

[0075] Figure 1 This is a schematic diagram of an embodiment of the present disclosure: The DNA tetrahedron biosensor is composed of two DNA tetrahedrons (FTDN-1, FTDN-2), and both FTDN-1 and FTDN-2 are composed of seven single-stranded DNA strands. S5 contains the AP site of the APE1 restriction site, and H2 contains the complementary sequence of miRNA-221. The Cy5 at the 3' end of H1 and the BHQ2 at the 5' end are close; similarly, the Cy3 at the 5' end of S2 and S4 (S2-2, S4-2) and the BHQ2 at the 3' end of S5 (5' end of S6) are close. The fluorescence of Cy3 and Cy5 is quenched, resulting in a lower background signal. In the presence of target APE1, APE1 specifically recognizes the AP site on the S5 chain and cleaves the S5 chain, thereby releasing the extended chain modified by Cy3 in FTDN-1 and combining with the complementary chain modified by Cy3 in FTDN-2, triggering an entropy-driven tetrahedral assembly reaction, Cy3 moves away from BHQ2, and the fluorescence signal of Cy3 rebounds; in the presence of target miRNA-221, H2 binds to miRNA-221, exposing the H2 binding site and hybridizing with H1, and Cy5 in H1 moves away from BHQ2, and the fluorescence signal of Cy5 rebounds. miRNA-221 is released and continues to hybridize with H2, realizing the double CHA cycle reaction within the tetrahedron of FTDN-1 and FTDN-2. When the two targets are present at the same time, the fluorescence signals of Cy3 and Cy5 rebound at the same time, and the change of fluorescence signal can realize the quantitative detection of the two targets.

[0076] Example 2: Feasibility analysis of a DNA tetrahedron biosensor for simultaneous detection of APE1 and miRNA-221.

[0077] First, the successful synthesis of TDN-1 and TDN-2 was verified by polyacrylamide gel electrophoresis. As DNA chains S1, S2, S2-2, S3, S4, and S4-2 were added in sequence, the molecular weight of the structures formed in lanes 1-7 gradually increased, and the corresponding electrophoretic migration rates also gradually slowed down. The bands formed in lanes 6 and 7 indicate that TDN-1 and TDN-2 were successfully prepared. Figure 2 A). By adding S5, S6 short chains and H1, H2 hairpin structures, the molecular weight of the structures formed in lanes 3 and 4 increased, indicating the successful synthesis of FTDN-1 and FTDN-2 ( Figure 2 B). Further verification was performed to determine whether an assembly reaction could occur between FTDN-1 and FTDN-2 in the presence of APE1 and miRNA-21. The results are shown in Figure 2. Figure 2 As shown in B, compared with FTDN-1 and FTDN-2 (lanes 3 and 4), a large molecular complex band (lane 5) appeared after the addition of APE1 and miRNA-221, indicating that FTDN-1 and FTDN-2 underwent an entropy-driven assembly reaction to generate a polymeric DNA tetrahedral assembly (FTDN-1 / FTDN-2).

[0078] The fluorescence intensity of different samples was measured to verify whether this method can detect and analyze APE1 and miRNA-221. Figure 2 C, the fluorescence signals of the reaction system and FTDN-1+FTDN-2 are low, indicating that before the addition of APE1, hybridization and connection between FTDN-1 and FTDN-2 cannot occur autonomously. The fluorescence signal of the APE1+FTDN-1 (no AP site) system is low, indicating that APE1 can only initiate the chain displacement reaction between FTDN-1 and FTDN-2 by specifically recognizing the AP site. After the addition of APE1, compared with the FTDN-1+APE1 reaction system, the fluorescence intensity of Cy3 in the FTDN-1+FTDN-2+APE1 system was significantly enhanced, further confirming that APE1 triggered the assembly reaction between FTDN-1 and FTDN-2, thereby realizing the signal amplification detection of APE1. For the detection of miRNA-221, such as Figure 2 D. After adding miRNA-221, the fluorescence intensity of Cy5 in the FTDN-1+FTDN-2+miRNA-221 system was significantly enhanced compared with that in the FTDN-1+miRNA-221 reaction system, further confirming that miRNA-221 triggered the dual intramolecular CHA assembly reaction of FTDN-1 and FTDN-2, thereby realizing the signal amplification detection of miRNA-221.

[0079] Example 3: Optimization results of experimental parameters for measuring APE1 and miRNA-221 using DNA tetrahedron sensor.

[0080] Firstly, the synthesis time of FTDN was optimized, such as Figure 3 As shown in A, after H1, H2 and S5 were reacted with TDN-1 for half an hour, 1 hour, 2 hours and 3 hours, there was no significant difference in the size of the FTDN-1 band formed. Therefore, 1 hour was selected as the synthesis time of FTDN. Secondly, the molar ratio of FTDN-1 and FTDN-2 was optimized. In the FTDN-1+FTDN-2+APE1+miRNA-221 system, when the molar ratio of FTDN-1 to FTDN-2 was 1:1, the relative fluorescence intensity reached the maximum value. Then the APE1 enzymatic reaction time and temperature were optimized. Figure 3 As shown in BC, the fluorescence intensity tends to be maximum at 60 minutes, and the optimal reaction temperature of the enzyme digestion reaction is 37°C. The CHA reaction optimization results for miRNA-21 detection showed that the optimal reaction time was 60 minutes and the reaction temperature was 37°C ( Figure 3 DE). Subsequent experiments adopted the above optimized experimental parameters.

[0081] Example 4: Application of DNA tetrahedron biosensor.

[0082] (1) Simultaneous detection of different concentrations of APE1 and miRNA-221 by DNA tetrahedron biosensor

[0083] Different concentrations of APE1 and miRNA-221 were added to the 100 nM probe to determine the sensitivity of the probe. The concentration of APE1 increased from 0 U / mL to 100 U / mL ( Figure 4 A). Figure 4 As shown in B, within the range of 0-10 U / mL, the fluorescence signal is proportional to the concentration of APE1. The correlation equation is Y = 118.57X + 1303.99 (R 2 =0.9976, Y: fluorescence intensity, X: APE1 concentration). According to the 3σ / S equation, the detection limit (LOD) of this method for APE1 was calculated to be 0.28U / mL. The concentration of miRNA-221 increased from 0nM to 100nM ( Figure 4 C) Figure 3-4 As shown in D, in the range of 0-10 nM, the fluorescence signal is proportional to the concentration of miRNA-221. The correlation equation is Y = 31.18X + 922.69 (R 2 =0.9988, Y: fluorescence intensity, X: concentration of miRNA-221). According to the equation of 3σ / S, the detection limit (LOD) of this method for miRNA-221 was calculated to be 0.26 nM. The above results show that this method can be used for sensitive detection of APE1 and miRNA-221.

[0084] (2) Selective experiments on the detection of APE1 and miRNA-221 using DNA tetrahedron biosensor.

[0085] Afterwards, the present application explored the selectivity of the method by comparing the fluorescence signal changes of FTDN-1 and FTDN-2 to the targets APE1 and miRNA-221 and other interfering proteins and miRNAs. Five enzymes, FPG, hOOG, UDG, hAAG, and T4 DNA ligase, and BSA protein were selected as controls to investigate the selectivity of the method for APE1. Figure 5 As shown in A, the Cy3 fluorescence signal of the reaction system will increase significantly only after APE1 is added. In contrast, when there are only other enzymes or proteins, the fluorescence signal is weak. This shows that the assembly reaction of FTDN-1 and FTDN-2 is triggered by APE1. miRNA-21, miRNA-222, miRNA-155 and miRNA-let-7 were selected as controls to investigate the selectivity of this method for miRNA-221. Figure 5 As shown in B, the Cy5 fluorescence signal of the reaction system will increase significantly only after the addition of miRNA-221. In contrast, when other interfering miRNAs are added, the fluorescence signal of the reaction system is weak. This indicates that the intramolecular CHA assembly reaction of FTDN-1 and FTDN-2 is triggered by miRNA. The above results show that this method has good selectivity for APE1 and miRNA-221.

[0086] (3) The results of DNA tetrahedron sensor screening of 12 anti-tumor compounds from traditional Chinese medicine for their effects on APE1 activity.

[0087] In order to evaluate the feasibility of this method for screening APE1 inhibitors, the positive drug inhibitor 7-nitroindole-2-carboxylic acid (NCA) was selected to study its effect on APE1 activity. Figure 6 As can be seen from AB, with the increase of NCA concentration, the fluorescence intensity gradually decreased. The IC value of NCA for APE1 50 The results showed that the constructed new biosensor can be used for the screening of APE1 inhibitors.

[0088] Abnormalities of APE1 are associated with diseases such as tumors and have the potential to serve as a diagnostic biomarker and therapeutic target for cancer. This method was applied to the screening of anti-tumor compounds derived from traditional Chinese medicine targeting APE1. Figure 6 As shown in Figure C, the four compounds, ellipticine hydrochloride, evodiamine, dehydroevodiamine hydrochloride, and 3,3'-diindolylmethane, have a significant inhibitory effect on APE1.

[0089] (4) DNA tetrahedron sensor was used for imaging analysis of APE1 and miRNA-221 in cells.

[0090] First, the selectivity of APE1 in FTDN-1 and FTDN-2 imaging cells was investigated using fluorescence imaging. Figure 7 As shown in A, after FTDN-1 (no AP site) + FTDN-2 group was incubated with MDA-MB-231 cells for 4 hours, the intracellular fluorescence signal was weak. This is because there is no AP site in FTDN-1 and it cannot be recognized by APE1. On the contrary, obvious green fluorescence can be observed after FTDN-1 + FTDN-2 is incubated with MDA-MB-231 cells, indicating that APE1 specifically recognizes the AP site and triggers the assembly reaction of FTDN-1 and FTDN-2, generating Cy3 fluorescence signals.

[0091] To evaluate the cellular uptake capacity of free H1 and H2 hairpins as well as FTDN-1 and FTDN-2, H1+H2 and FTDN-1+FTDN-2 were incubated with cells for 4 h, respectively. Figure 7 As shown in Figure C, the intracellular fluorescence signal in the H1+H2 treatment group was weak, which was due to the difficulty of free H1 and H2 to enter the cell autonomously, and the unstable hairpin structure was easily degraded by enzymes. In contrast, bright red fluorescence was observed in the cells in the FTDN-1+FTDN-2 treatment group, indicating that intracellular miRNA-221 successfully triggered the CHA reaction in the tetrahedron, resulting in the separation of Cy5 and BHQ2, and then generating Cy5 signals. The above results show that DNA tetrahedron has good biological stability, can load DNA structure into cells without transfection, and is more easily taken up by cells, which is conducive to the amplification and imaging of the fluorescence signals of APE1 and miRNA-221 in cells.

[0092] To evaluate the expression levels of APE1 and miRNA-221 in different cells, FTDN-1 and FTDN-2 were incubated with MCF-10A, MDA-MB-231, MCF-7, A549, and HeLa cells, respectively. Figure 8 As shown, the fluorescence intensity in MCF-10A cells is the lowest, indicating that the expression of APE1 and miRNA-221 in MCF-10A cells is low, while the fluorescence intensity in MDA-MB-231, MCF-7, A549 and HeLa cells is high, indicating that the expression of APE1 and miRNA-221 in these four tumor cells is high. The above results are consistent with literature reports, that is, the expression of APE1 and miRNA-221 in tumor cells is much higher than that in normal cells. The biosensor can be used to make a preliminary distinction and judgment between tumor cells and normal cells.

[0093] The above-mentioned embodiments only express several implementation methods of the present application, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the present application. It should be pointed out that, for a person of ordinary skill in the art, several variations and improvements can be made without departing from the concept of the present application, and these all belong to the protection scope of the present application. Therefore, the protection scope of the present application shall be subject to the attached claims.

[0094] The above description is only a preferred embodiment of the present application and is not intended to limit the present application. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present application should be included in the protection scope of the present application.

Claims

1. A DNA tetrahedron biosensor, characterized in that: The DNA tetrahedron biosensor includes FTDN-1 and FTDN-2; The FTDN-1 is formed by hybridization and assembly of the extended sequences of the four vertices of TDN-1 with the H1 and H2 hairpin structures modified by Cy5 and BHQ2 and the S5 single strand modified by BHQ2; the TDN-1 is obtained by the mixed reaction of the S1 single strand, the S2 single strand, the S3 single strand and the S4 single strand; The FTDN-2 is formed by hybridization and assembly of the extended sequences of the four vertices of TDN-2 with the H1 and H2 hairpin structures modified by Cy5 and BHQ2 and the S6 single strand modified by BHQ2; the TDN-2 is obtained by the mixed reaction of the S1 single strand, the S2-2 single strand, the S3 single strand and the S4-2 single strand; The sequences from 5' to 3' of S1, S2, S3, S4, S2-2, S4-2, S5, S6, H1, and H2 are shown as SEQ ID NO. 1 to SEQ ID NO. 10, respectively.

2. A method for constructing a DNA tetrahedron biosensor according to claim 1, characterized in that: include: The S1 single chain, the S2 single chain, the S3 single chain and the S4 single chain were mixed in an equal molar ratio to obtain TDN-1; The S1 single chain, the S2-2 single chain, the S3 single chain and the S4-2 single chain were mixed in an equal molar ratio to obtain TDN-2; After the H1 single strand and the H2 single strand are reacted, they are annealed to form the H1 and H2 hairpin structures; The TDN-1 is mixed with the H1, H2 hairpin structures and S5 single chain, and incubated to obtain FTDN-1; The TDN-2 is mixed with the H1, H2 hairpin structures and S6 single chain, and incubated to obtain FTDN-2.

3. The method for constructing a DNA tetrahedron biosensor according to claim 2, characterized in that: The step of mixing the S1 single chain, the S2 single chain, the S3 single chain and the S4 single chain in an equal molar ratio to obtain TDN-1 comprises: S1 single chain, S2 single chain, S3 single chain and S4 single chain were mixed in TE buffer at an equal molar ratio, reacted at 95°C for 10 minutes, placed on ice for 5 minutes to quickly cool the solution, and kept at 4°C for at least 35 minutes to obtain TDN-1.

4. The method for constructing a DNA tetrahedron biosensor according to claim 2, characterized in that: The step of mixing the S1 single chain, the S2-2 single chain, the S3 single chain and the S4-2 single chain in an equal molar ratio to obtain TDN-2 comprises: S1 single chain, S2-2 single chain, S3 single chain and S4-2 single chain were mixed in TE buffer at an equal molar ratio, reacted at 95°C for 10 minutes, placed on ice for 5 minutes to quickly cool the solution, and kept at 4°C for at least 35 minutes to obtain TDN-2.

5. The method for constructing a DNA tetrahedron biosensor according to claim 2, characterized in that: The step of reacting the H1 single strand and the H2 single strand and then annealing them to form the H1 and H2 hairpin structures comprises: The H1 single strand and the H2 single strand were placed at 95°C for 5 minutes and gradually annealed to 25°C to form H1 and H2 hairpin structures.

6. The method for constructing a DNA tetrahedron biosensor according to claim 2, characterized in that: The step of mixing the TDN-1 with the H1, H2 hairpin structures, and S5 single strand, and incubating the mixture to obtain FTDN-1 comprises: The TDN-1 was mixed evenly with the H1 and H2 hairpin structures and the S5 single chain, and incubated at 37° C. for 1 hour to obtain FTDN-1.

7. The method for constructing a DNA tetrahedron biosensor according to claim 2, characterized in that: The step of mixing the TDN-2 with the H1, H2 hairpin structures, and S6 single strands and incubating them to obtain FTDN-2 comprises: The TDN-2 was mixed evenly with the H1 and H2 hairpin structures and the S6 single strand, and incubated at 37° C. for 1 hour to obtain FTDN-2.

8. Use of the DNA tetrahedron biosensor according to claim 1 in the simultaneous detection of APE1 enzyme and miRNA-221.

9. Use of the DNA tetrahedron biosensor according to claim 8 in the simultaneous detection of APE1 enzyme and miRNA-221, characterized in that: The detection conditions were: excitation wavelength: 530 nm and 635 nm, excitation slit: 10 nm, emission slit: 10 nm, voltage: 700 V.

10. Use of the DNA tetrahedron biosensor according to claim 1 in drug screening.

Citation Information

Cited By

  • Prostate cancer diagnostic kit based on biosensor chip

    CN120505422A